. Overview We are a New York City based clinical-stage biopharmaceutical company committed to advancing transformative therapies for the treatment of cancer and rare diseases. We were founded on the principle of applying modern scientific, regulatory or manufacturing advancements to established mechanisms in order to create new development opportunities. We prioritize creativity, integrity and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment opti...
expected 2026-11-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-10 | 2025-12-31 | 0001213900-26-025433 | EDGAR | 83K words |
| 2025-03-05 | 2024-12-31 | 0001213900-25-020368 | EDGAR | 81K words |
| 2024-03-13 | 2023-12-31 | 0001213900-24-021982 | EDGAR | 69K words |
| 2023-03-08 | 2022-12-31 | 0001213900-23-018373 | EDGAR | 69K words |
| 2022-03-09 | 2021-12-31 | 0001213900-22-011208 | EDGAR | 73K words |
| 2021-03-11 | 2020-12-31 | 0001213900-21-014709 | EDGAR | 68K words |
| 2020-03-20 | 2019-12-31 | 0001171843-20-001860 | EDGAR | 60K words |
| 2019-03-13 | 2018-12-31 | 0001171843-19-001687 | EDGAR | 90K words |
| 2018-03-14 | 2017-12-31 | 0001171843-18-001934 | EDGAR | 88K words |
| 2017-03-16 | 2016-12-31 | 0001171843-17-001555 | EDGAR | 88K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-11 | 2026-06-30 | 0001213900-26-087508 | EDGAR | 22K words |
| 2025-11-10 | 2025-09-30 | 0001213900-25-107881 | EDGAR | 22K words |
| 2025-08-11 | 2025-06-30 | 0001213900-25-073942 | EDGAR | 21K words |
| 2025-05-08 | 2025-03-31 | 0001213900-25-040811 | EDGAR | 19K words |
| 2024-11-12 | 2024-09-30 | 0001213900-24-096252 | EDGAR | 21K words |
| 2024-08-06 | 2024-06-30 | 0001213900-24-065380 | EDGAR | 21K words |
| 2024-05-02 | 2024-03-31 | 0001213900-24-038757 | EDGAR | 19K words |
| 2023-11-03 | 2023-09-30 | 0001213900-23-083013 | EDGAR | 40K words |
| 2023-08-03 | 2023-06-30 | 0001213900-23-062782 | EDGAR | 39K words |
| 2023-05-04 | 2023-03-31 | 0001213900-23-036113 | EDGAR | 37K words |
| 2022-11-03 | 2022-09-30 | 0001213900-22-069010 | EDGAR | 40K words |
| 2022-08-09 | 2022-06-30 | 0001213900-22-045922 | EDGAR | 40K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-11 | 0001213900-26-087506 | EDGAR | 3K words |
| 2026-03-30 | 0001213900-26-035971 | EDGAR | 1K words |
| 2026-03-10 | 0001213900-26-025432 | EDGAR | 4K words |
| 2026-02-24 | 0001213900-26-019617 | EDGAR | 6K words |
| 2025-12-15 | 0001213900-25-121687 | EDGAR | 1K words |
| 2025-12-08 | 0001213900-25-119242 | EDGAR | 24K words |
| 2025-12-03 | 0001213900-25-117577 | EDGAR | 2K words |
| 2025-11-19 | 0001213900-25-112383 | EDGAR | 3K words |
| 2025-11-10 | 0001213900-25-107873 | EDGAR | 3K words |
| 2025-08-11 | 0001213900-25-073937 | EDGAR | 3K words |
209 total filings indexed. 177 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001359931 |
| Ticker | TARA |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Website | https://www.protaratx.com |
| Listed | 2020-01-10 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/TARA (~200 tokens, structured JSON with cryptographic provenance)